Biohaven Ltd.
General ticker "BHVN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.4B (TTM average)
Biohaven Ltd. does not follow the US Stock Market performance with the rate: -22.8%.
Estimated limits based on current volatility of 3.6%: low 9.09$, high 9.78$
Factors to consider:
- Earnings expected soon, date: 2026-05-11 bmo
- Total employees count: 30000 (+3132.8%) as of 2022
- Top business risk factors: Inability to raise capital, Liquidity and credit risks, Dependence on limited products, System failures and security breaches, Volatility in common share prices
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.64$, 18.84$]
- 2026-12-31 to 2027-12-31 estimated range: [5.86$, 16.71$]
Financial Metrics affecting the BHVN estimates:
- Negative: with PPE of -1.6 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -51.12 <= 0.07
- Negative: Shareholder equity ratio, % of 11.53 <= 19.49
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 25.21 > -0.65
Short-term BHVN quotes
Long-term BHVN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $436.05MM | $885.11MM | $745.38MM |
| Operating Income | $-436.05MM | $-885.11MM | $-745.38MM |
| Non-Operating Income | $26.50MM | $39.42MM | $8.00MM |
| R&D Expense | $373.28MM | $795.87MM | $635.07MM |
| Income(Loss) | $-409.55MM | $-845.69MM | $-737.38MM |
| Taxes | $-1.38MM | $0.73MM | $1.44MM |
| Profit(Loss)* | $-408.17MM | $-846.42MM | $-738.82MM |
| Stockholders Equity | $427.98MM | $423.44MM | $52.07MM |
| Assets | $513.21MM | $615.11MM | $451.45MM |
| Operating Cash Flow | $-331.73MM | $-582.45MM | $-609.44MM |
| Capital expenditure | $3.05MM | $4.05MM | $0.71MM |
| Investing Cash Flow | $129.83MM | $-244.97MM | $300.56MM |
| Financing Cash Flow | $211.91MM | $677.77MM | $439.12MM |
| Earnings Per Share** | $-5.73 | $-9.28 | $-6.86 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.